The Texas Forensic Science Commission held its quarterly meeting on January 31, 2025, addressing several key agenda items related to forensic practices and laboratory operations. The meeting commenced with the appointment of Dr. Koval, Mr. Visemak, and Mr. Daniel to a panel, which was unanimously approved by the members present.

The first significant discussion focused on an incident reported by NMS Labs concerning a miscalculation in drug chemistry measurements. The lab identified that an analyst had incorrectly applied the root sum squared method for calculating measurement uncertainty, leading to an underestimation of cannabinoid quantitation. The issue stemmed from inadequate training and guidance provided to the technical team. The lab has since taken corrective measures, ensuring that all staff are now properly trained on measurement uncertainty. Following a thorough review, the Commission agreed with the staff's recommendation to take no further action on this matter.

Next, the Commission reviewed another report from NMS Labs regarding an automated method for testing cocaine and its metabolites. This method, which utilized robotics, failed due to insufficient protein precipitation during sample extraction. Although three cases were affected, none originated from Texas. The lab has amended the reports for these cases, and the Commission again concurred with the recommendation for no further action.

After these discussions, the meeting was briefly recessed for a music interlude, allowing members to regroup before continuing with the agenda. Upon reconvening, the Commission prepared to address additional items, with Dr. Drake stepping in to preside over the next discussion.

Overall, the meeting highlighted the Commission's commitment to maintaining high standards in forensic science through rigorous review processes and proactive training initiatives. The next steps will involve continued monitoring of laboratory practices and ensuring compliance with updated protocols.